NET PROFIT (x1000 EUR)
EMPLOYEES
Edwards Lifesciences A/S
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
0
|
0 |
| Earnings before taxes |
537
|
695
|
699 |
| Total assets |
4,196
|
3,906
|
5,544 |
| Current assets |
4,190
|
0
|
0 |
| Current liabilities |
1,333
|
1,427
|
3,608 |
| Equity capital |
2,860
|
2,475
|
1,936 |
| - share capital |
67
|
67
|
67 |
| Employees (average) |
7
|
7
|
7 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
68.2%
|
63.4%
|
34.9% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) | |||
| Current ratio |
314.3%
|
0%
|
0% |
| Return on equity (ROE) |
18.8%
|
28.1%
|
36.1% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.